Logo image of LEG.DE

LEG IMMOBILIEN SE (LEG.DE) Stock Fundamental Analysis

FRA:LEG - DE000LEG1110 - Common Stock

73.65 EUR
+0.05 (+0.07%)
Last: 8/27/2025, 9:38:53 AM
Fundamental Rating

4

Taking everything into account, LEG scores 4 out of 10 in our fundamental rating. LEG was compared to 68 industry peers in the Real Estate Management & Development industry. While LEG is still in line with the averages on profitability rating, there are concerns on its financial health. LEG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

LEG had positive earnings in the past year.
In the past year LEG had a positive cash flow from operations.
LEG had positive earnings in 4 of the past 5 years.
LEG had a positive operating cash flow in each of the past 5 years.
LEG.DE Yearly Net Income VS EBIT VS OCF VS FCFLEG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.90%, LEG is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
The Return On Equity of LEG (7.79%) is better than 83.82% of its industry peers.
With a Return On Invested Capital value of 1.98%, LEG perfoms like the industry average, outperforming 54.41% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for LEG is in line with the industry average of 3.72%.
The last Return On Invested Capital (1.98%) for LEG is above the 3 year average (1.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.9%
ROE 7.79%
ROIC 1.98%
ROA(3y)-2.23%
ROA(5y)2.11%
ROE(3y)-5.85%
ROE(5y)4.04%
ROIC(3y)1.76%
ROIC(5y)1.7%
LEG.DE Yearly ROA, ROE, ROICLEG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

LEG's Profit Margin of 44.53% is fine compared to the rest of the industry. LEG outperforms 79.41% of its industry peers.
In the last couple of years the Profit Margin of LEG has declined.
LEG's Operating Margin of 45.26% is fine compared to the rest of the industry. LEG outperforms 69.12% of its industry peers.
In the last couple of years the Operating Margin of LEG has declined.
With a Gross Margin value of 49.04%, LEG perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
LEG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 45.26%
PM (TTM) 44.53%
GM 49.04%
OM growth 3Y-4.69%
OM growth 5Y-2.56%
PM growth 3Y-69.54%
PM growth 5Y-45.04%
GM growth 3Y-4.06%
GM growth 5Y-2.36%
LEG.DE Yearly Profit, Operating, Gross MarginsLEG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LEG is destroying value.
The number of shares outstanding for LEG has been increased compared to 1 year ago.
Compared to 5 years ago, LEG has more shares outstanding
Compared to 1 year ago, LEG has a worse debt to assets ratio.
LEG.DE Yearly Shares OutstandingLEG.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
LEG.DE Yearly Total Debt VS Total AssetsLEG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

LEG has an Altman-Z score of 0.71. This is a bad value and indicates that LEG is not financially healthy and even has some risk of bankruptcy.
LEG has a worse Altman-Z score (0.71) than 64.71% of its industry peers.
The Debt to FCF ratio of LEG is 24.32, which is on the high side as it means it would take LEG, 24.32 years of fcf income to pay off all of its debts.
LEG's Debt to FCF ratio of 24.32 is in line compared to the rest of the industry. LEG outperforms 51.47% of its industry peers.
LEG has a Debt/Equity ratio of 0.94. This is a neutral value indicating LEG is somewhat dependend on debt financing.
LEG's Debt to Equity ratio of 0.94 is on the low side compared to the rest of the industry. LEG is outperformed by 61.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 24.32
Altman-Z 0.71
ROIC/WACC0.6
WACC3.27%
LEG.DE Yearly LT Debt VS Equity VS FCFLEG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

LEG has a Current Ratio of 0.30. This is a bad value and indicates that LEG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of LEG (0.30) is worse than 80.88% of its industry peers.
LEG has a Quick Ratio of 0.30. This is a bad value and indicates that LEG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of LEG (0.30) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.3
LEG.DE Yearly Current Assets VS Current LiabilitesLEG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.11% over the past year.
The Earnings Per Share has been decreasing by -3.40% on average over the past years.
LEG shows a small growth in Revenue. In the last year, the Revenue has grown by 7.27%.
The Revenue has been growing by 10.00% on average over the past years. This is quite good.
EPS 1Y (TTM)4.11%
EPS 3Y23.02%
EPS 5Y-3.4%
EPS Q2Q%-3.17%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y10.71%
Revenue growth 5Y10%
Sales Q2Q%8.26%

3.2 Future

LEG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.65% yearly.
Based on estimates for the next years, LEG will show a small growth in Revenue. The Revenue will grow by 5.21% on average per year.
EPS Next Y15.05%
EPS Next 2Y8.06%
EPS Next 3Y6.65%
EPS Next 5YN/A
Revenue Next Year16.93%
Revenue Next 2Y9.33%
Revenue Next 3Y5.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LEG.DE Yearly Revenue VS EstimatesLEG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
LEG.DE Yearly EPS VS EstimatesLEG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.84, which indicates a correct valuation of LEG.
73.53% of the companies in the same industry are more expensive than LEG, based on the Price/Earnings ratio.
LEG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
LEG is valuated correctly with a Price/Forward Earnings ratio of 12.01.
Based on the Price/Forward Earnings ratio, LEG is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
LEG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.84
Fwd PE 12.01
LEG.DE Price Earnings VS Forward Price EarningsLEG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LEG's Enterprise Value to EBITDA is on the same level as the industry average.
66.18% of the companies in the same industry are more expensive than LEG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.49
EV/EBITDA 23.65
LEG.DE Per share dataLEG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

LEG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of LEG may justify a higher PE ratio.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y8.06%
EPS Next 3Y6.65%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.74%, LEG has a reasonable but not impressive dividend return.
LEG's Dividend Yield is a higher than the industry average which is at 7.99.
Compared to an average S&P500 Dividend Yield of 2.34, LEG pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.74%

5.2 History

The dividend of LEG decreases each year by -9.38%.
Dividend Growth(5Y)-9.38%
Div Incr Years0
Div Non Decr Years1
LEG.DE Yearly Dividends per shareLEG.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 2025 2 4 6

5.3 Sustainability

DP0%
EPS Next 2Y8.06%
EPS Next 3Y6.65%
LEG.DE Yearly Income VS Free CF VS DividendLEG.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

LEG IMMOBILIEN SE

FRA:LEG (8/27/2025, 9:38:53 AM)

73.65

+0.05 (+0.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners63.18%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.57B
Analysts75.45
Price Target90.52 (22.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.74%
Yearly Dividend2.06
Dividend Growth(5Y)-9.38%
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-21.21%
Min EPS beat(2)-21.46%
Max EPS beat(2)-20.96%
EPS beat(4)1
Avg EPS beat(4)-8.9%
Min EPS beat(4)-32.58%
Max EPS beat(4)39.41%
EPS beat(8)2
Avg EPS beat(8)-6.72%
EPS beat(12)3
Avg EPS beat(12)-19.6%
EPS beat(16)3
Avg EPS beat(16)-39.05%
Revenue beat(2)2
Avg Revenue beat(2)40.46%
Min Revenue beat(2)20.85%
Max Revenue beat(2)60.06%
Revenue beat(4)2
Avg Revenue beat(4)17.13%
Min Revenue beat(4)-6.68%
Max Revenue beat(4)60.06%
Revenue beat(8)4
Avg Revenue beat(8)15.89%
Revenue beat(12)7
Avg Revenue beat(12)17.96%
Revenue beat(16)11
Avg Revenue beat(16)22.5%
PT rev (1m)0.07%
PT rev (3m)-0.5%
EPS NQ rev (1m)2.67%
EPS NQ rev (3m)0.11%
EPS NY rev (1m)0.22%
EPS NY rev (3m)0.22%
Revenue NQ rev (1m)-15.4%
Revenue NQ rev (3m)11.6%
Revenue NY rev (1m)-12.96%
Revenue NY rev (3m)-12.96%
Valuation
Industry RankSector Rank
PE 13.84
Fwd PE 12.01
P/S 4.14
P/FCF 13.49
P/OCF 12.79
P/B 0.72
P/tB 0.72
EV/EBITDA 23.65
EPS(TTM)5.32
EY7.22%
EPS(NY)6.13
Fwd EY8.32%
FCF(TTM)5.46
FCFY7.41%
OCF(TTM)5.76
OCFY7.82%
SpS17.8
BVpS101.81
TBVpS101.74
PEG (NY)0.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.9%
ROE 7.79%
ROCE 3.52%
ROIC 1.98%
ROICexc 2.05%
ROICexgc 2.05%
OM 45.26%
PM (TTM) 44.53%
GM 49.04%
FCFM 30.66%
ROA(3y)-2.23%
ROA(5y)2.11%
ROE(3y)-5.85%
ROE(5y)4.04%
ROIC(3y)1.76%
ROIC(5y)1.7%
ROICexc(3y)1.79%
ROICexc(5y)1.74%
ROICexgc(3y)1.79%
ROICexgc(5y)1.75%
ROCE(3y)3.13%
ROCE(5y)3.03%
ROICexcg growth 3Y6.99%
ROICexcg growth 5Y-0.28%
ROICexc growth 3Y7.57%
ROICexc growth 5Y-0.05%
OM growth 3Y-4.69%
OM growth 5Y-2.56%
PM growth 3Y-69.54%
PM growth 5Y-45.04%
GM growth 3Y-4.06%
GM growth 5Y-2.36%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 24.32
Debt/EBITDA 11.46
Cap/Depr 94.54%
Cap/Sales 1.67%
Interest Coverage 3.67
Cash Conversion 68.76%
Profit Quality 68.86%
Current Ratio 0.3
Quick Ratio 0.3
Altman-Z 0.71
F-Score5
WACC3.27%
ROIC/WACC0.6
Cap/Depr(3y)67.45%
Cap/Depr(5y)56.65%
Cap/Sales(3y)3.16%
Cap/Sales(5y)2.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.11%
EPS 3Y23.02%
EPS 5Y-3.4%
EPS Q2Q%-3.17%
EPS Next Y15.05%
EPS Next 2Y8.06%
EPS Next 3Y6.65%
EPS Next 5YN/A
Revenue 1Y (TTM)7.27%
Revenue growth 3Y10.71%
Revenue growth 5Y10%
Sales Q2Q%8.26%
Revenue Next Year16.93%
Revenue Next 2Y9.33%
Revenue Next 3Y5.21%
Revenue Next 5YN/A
EBIT growth 1Y6.66%
EBIT growth 3Y5.52%
EBIT growth 5Y7.18%
EBIT Next Year10.61%
EBIT Next 3Y5.28%
EBIT Next 5YN/A
FCF growth 1Y-5.84%
FCF growth 3Y6.85%
FCF growth 5Y6.25%
OCF growth 1Y-5.88%
OCF growth 3Y7.26%
OCF growth 5Y6.53%